Warung Bebas
Showing posts with label Interna. Show all posts
Showing posts with label Interna. Show all posts

Wednesday, 19 October 2011

Chronic Kidney Disease (CKD) Evaluation and Management

EVALUATION and MANAGEMENT
What should we do if we have patient with Chronic Kidney Disease? Today, Mbah Dukun Bagong, modern shaman from medical and health information explains how to treat and give therapy for patient with chronic Kidney Disease (CKD). If someone has been established, there is an increased risk for Chronic Kidney Disease (CKD), but not yet exposed to CKD, it needs to be evaluated as below:



Clinical evaluation for all patients:
 Measurement of blood pressure
 serum creatinine to measure GFR
 The ratio of protein - creatinine ratio or albumin - creatinine morning, or when urine specimens (untimed spot urine specimen)
 Examination of urine sediment or disptik for detection of red blood cells and white blood cells
Clinical evaluation for a particular patient (depending on risk factors):
 ultrasound (eg for patients with symptoms of urinary tract obstruction; infection or stones, family history of polycystic kidney disease)
 serum electrolytes (Na, K, Cl, bicarbonate)
 Concentration of urine (specific gravity or osmolality)
 urine acidity (pH)

             It has been mentioned above (the definition of CKD) that markers of kidney damage is the presence of abnormalities in the composition of the blood or urine, or radiological abnormalities. Although there is some indication, but the NKF K / DOQI stresses the importance of proteinuria as a marker of kidney damage. The term proteinuria showed an increased excretion of urine for albumin, other specific proteins, or total protein. While the term specifically albumin showed an increase in urinary albumin excretion. Microalbuminuria indicates that the excretion of albumin above the normal value, but below levels that can be detected by tests for total protein. In adults with an increased risk of CKD is advisable to check with spot urine albuminuria, both with special disptik ratio for albumin or albumin / creatinine

Patients with CKD should be evaluated to determine:
a. Diagnosis (type of kidney disease)
b. comorbid conditions
c. Severity, through the determination of the degree of renal function
d. Complications, related to the degree of renal function
e. The risk of loss of kidney function
f. Risk of cardiovascular disease

For all patients that have been defined as CKD, the evaluation lab to do are:
 serum creatinine to determine GFR
 The ratio of protein / creatinine ratio or albumin / creatinine morning or when the spot urine
 Examination of urine sediment or dipstick for red blood cells and white blood cells
 radiological examination of kidney, usually ultrasound
 serum electrolytes (Na, K, Cl, bicarbonate)
Guidelines for K / DOQI 2002 recommends that interventions that are considered effective in inhibiting the progression are:
1. controlling blood sugar levels
2. control of blood pressure
3. RAA system activity control

              The American Diabetes Association (ADA) recommends the use of ACE inhibitors in all patients with DM who proved existing kidney disorders (microalbuminuria or proteinuria), view or presence of hypertension, as long as the use of these drugs are contraindicated and not cause complications.
ACE inhibitors and angiotensin receptor antagonists (ARBs) have a special protective role in patients with diabetic kidney disease and non-diabetic, besides lowering systemic blood pressure also lowers blood pressure and capillary filtration glomeruler proteins thus slowing progression of kidney damage. In addition both drugs also reduced cell proliferation and fibrosis caused by angiotensin 2.
While interventions are still under evaluation and are not yet conclusive
1. Restriction of protein in the diet
2. Lipid-lowering drugs
3. correction of anemia

Some Practical Aspects Management of CKD Patients
In everyday practice management of CKD is as follows:
1. Basic treatment of the disease
2. Control of water and salt balance
3. Diets low in protein, high aklori
4. control of blood pressure
5. control of electrolyte imbalance and acid-base
6. prevention and treatment of renal osteodystrophy (ODR)
7. treatment of specific symptoms uremi
8. early detection and treatment of infections
9. adjustment of drug delivery
10. detection and treatment of complications
11. preparation for dialysis and transplantation.

1. Basic Medicine
Treatment that can still be corrected absolutely must be done. Including, control of blood pressure, blood sugar regulation in diabetic patients, correction if there is obstruction of the urinary tract, as well as the treatment of urinary tract infection (UTI).

2. Control of Water and Salt Balance
Fluid administration adjusted to the production of urine. Namely 24-hour urine output plus 500 ml. Salt intake depends efaluasi ekektrolit, generally in the limit 40-120 mEq (920-2760 mg). Normal diet contains an average of 150 mEq. High doses of furosemide can still be used in early CKD, but in the next phase is no longer useful and the obstruction is contraindicated. Weighing, monitoring urine output and fluid balance records will assist the management of fluid and salt balance.

3. And High Protein Diet Low Calorie
Restricted protein intake from 0.6 to 0.8 grams / kg / day. Average daily protein requirements in patients with Chronic Renal Failure is 20-40 grams. Caloric needs at least 35 kcal / kg / day. High protein low calorie diet will improve the complaints of nausea, lower BUN and will improve symptoms. Besides low-protein diet will inhibit progression of decline in renal physiology.

4. management of Hypertension
In contrast to the control of hypertension in general, the CKD problem of fluid restriction absolutely necessary. Target blood pressure 125/75 is required to inhibit the rate of progression of decline in renal physiology. -ACE inhibitors and ARBs are expected to inhibit the progression of CKD. Serial monitoring of renal physiology needs to be done in the early treatment of hypertension when used ACE-inhibitors and ARBs. If the suspected presence of renal artery stenosis, ACE inhibitors are contra-indications.

5. Control of Electrolyte Balance and Acid-Base
The main electrolyte balance disorders in CKD is hyperkalemia and asidosis.Hiperkalemia may remain asymptomatic despite life-threatening. EKG changes, sometimes only emerge after a life-threatening hyperkalemia. Prevention includes:
a) low-potassium diet
avoid fruit (bananas, oranges, tomatoes) and vegetables of excess
b) avoiding the use of K-sparring diuretics
Treatment of hyperkalemia depends on the degree of emergency:
Intensive - glukonase calcicus intravenous (10-20 ml of 10% Ca gluconate)
- Intravenous glucose (25-50 ml of glucose 50%)
- 10-20 units of insulin
- Intravenous sodium bicarbonate (25-100 ml 8.4% NaHCO3)
  can be used also fast-acting insulin 2 U are mixed into a 25 cc 40% dextrose, administered iv bolus.
Increases the expression of potassium
   • Furosemide
   • K-exchange resin
• Dialysis

Acidosis led to complaints of nausea, weakness, water-hunger and drowsiness. Intravenous treatment with NaHCO3 only given in severe acidosis, whereas if it is not life threatening can be administered either by mouth.

6. Prevention and Treatment of ROD
Included in this action is
a. control hiperphosphatemia
Serum P levels should be maintained less than 6 mg / dl.dengan way low phosphorus diet alone is not enough sometimes, so it should be given phosphate binder medication. 300-1800 mg of aluminum hydroxide is supplied with a meal. This method is now abandoned because of side effects of aluminum intoxication and constipation. As another option may be given 500-3000 mg of calcium carbonate with meals with a profit increase calcium intake and also for the correction of hypocalcemia. Foods that contain high phosphorus should be avoided such as milk, cheese, yogurt, ice cream, fish and nuts. Hiperphosphatemia control can also inhibit progression of decline in renal physiology.
b. Supplements of vitamin D3 active
1:25 dihydroxy vitamin D3 (calcitriol) is given only if the normal P levels. Limitation provision if the Ca × P <65. The dose given was 0:25 micrograms / day.
c. Paratiroidektomi
Done if the ODR process continues

7. Specific Treatment of Symptoms Uremi
Included here is the symptomatic treatment of pruritus, complaint handling gastrointestinaldan anemia. Diets low in protein, P-control as well as giving diphenhydramine may improve pruritus complaints. Low-protein diets also improve complaints of anorexia and nausea. Anemia that occurs in CKD mainly caused by a deficiency of the hormone erythropoietin. It also can be caused by defisisensi Fe, folic acid or B12. administration of recombinant erythropoietin in patients with CKD who underwent HD will improve the quality of life, can also be given to pre-HD patients with CKD. Before giving erythropoietin and iron supplementation is required evaluation undergraduate levels, TIBC, and ferritin. I.

8. Detection and Treatment of Infection
Patients with CKD is an patients with a low immune response, so the possibility of infection should always be considered. Febrile symptoms sometimes do not emerge because of this low immune response.

9. Dispensing Adjustment
Some drugs require dose adjustment due to excretion of metabolites through the kidneys. The use of nephrotoxic drugs such as aminoglycosides, co-trimoxazole, amphotericin should dihndari and diberika only on special circumstances. NSAIDs also decrease kidney function. Tetracycline also reduced protein catabolism. Nitrofurantoin should be avoided and the use of K-sparing diuretics should also be careful because it causes hyperkalemia.
10. Detection and Treatment of Complications
With more and continued PGK greater likelihood of complications arise. Some complications are indications for immediate commencement of hemodialysis (HD) even though the patient has not reached the stage of CKD stage 5.

Complications are an indication for HD action include:
a) uremic encephalopathy
b) Pericarditis or pleuritis
c) progressive peripheral neuropathy
d) progressive ODR
e) hyperkalemia that can not be controlled with medical treatment
f) overload syndrome
g) a life-threatening infections
h) Social conditions

11. Preparation of Dialysis and Transplantation
Patients with CKD and their families must be informed early on that at some point people will goes a HD or renal transplantation. Preparation of vascular access should've done before creatinine clearance below 15 ml / min. Vascular access creation is recommended if creatinine clearance was below 20 ml / min. Need to restrict blood vessel puncture area that will be used for limb-vascular access. Besides the preparation of medical terms is also important to non-medical preparation.



For Indonesian Language click here



Thursday, 13 October 2011

How to know and diagnose CHRONIC KIDNEY DISEASE

CLINICAL MANIFESTATIONS
CKD patients with blood urea of less than 150 mg%, usually without any complaints or symptoms and are often found by chance on routine examination. Clinical picture more evident when the blood urea more than 200 mg%. At the initial level of CKD with a GFR less than 25% of normal, clinical picture is very minimal, only albuminuria, hyperuricaemia, and hypertension.

Clinical picture of severe CKD accompanied by azotemia extremely complex syndrome, including abnormalities of various organs such as:
a.    abnormalities hemopoeisis
Anemia nomokrom normositer (MCHC 32-36%) and normositer (MCV 78-94 CU).
b.    Gastrointestinal disorders
Nausea and vomiting are often a major complaint of most patients with chronic renal failure, especially in the terminal stage, Hiccup, azotemia stomatitis is characterized by dry mucous lesions accompanied by extensive ulceration stomatitis is called bright-red, parotid gland enlargement, and pancreatitis.
c.    eye disorders
Vision loss (amaurosis azotemia) in only a minority of patients. Optic nerve disorder that causes symptoms of nystagmus, miosis, and pupil asymmetry. Abnormalities of the retina (retinopathy), keratopathy.
d.    skin disorders
Itchy, dry and scaly skin.
e.    Serous membrane abnormalities
Pleuritis, pericarditis is often encountered in chronic renal failure, especially in the terminal stage.
f.    neuropsychiatric disorders
Mild mental disorders such as emotionally unstable, dilution, insomnia, depression. Severe mental disorders such as confusion, dilution, and not infrequently with symptoms of psychosis. Mild or severe mental disorders are often found in patients with or without hemodialysis, and depending on the basic personality (personality).
Neurological disorders such as muscular twitching or muscle spasms are often found in patients already heavy, plunging into a coma. The attack is accompanied grandma focal abnormalities often found in the terminal stage.
g.    Cardiopulmonal system disorders
Congestive heart failure, hypertension, peripheral vascular calcification, pericarditis, pulmonary azotemia (uremic lung)


DIAGNOSIS
a. History and physical examination diagnosis
History should be directed to collect all complaints relating to the retention or accumulation of toxins azotemia, Chronic Renal Failure etiology, course of disease, including all factors that can aggravate kidney physiology. It is also necessary data about the patient's disease history, and also data showing a gradual decline in renal physiology.
b.    laboratory tests
1)      Examination of renal physiology
Examination of urea & serum creatinine and serum uric acid is sufficient as screened for renal physiology. There was also the examination of creatinine clearance and radionuclide (gamma camera imaging) is almost close to the actual renal physiology.
2)      Routine Urinalysis
Albuminuria more than 3.5 grams per day and non-selective accompanied by abnormalities of sediment (erythrocytes Uriah, leukosituria and silinderuria) more often found in glomerulonefropati (primary or secondary).
3)      Microbiology urine (CFU per ml of urine)
Worsening of renal physiology that hard to explain UTI should be suspected as a cause by CFU per ml of urine more than 105.
4)      Blood Chemistry
Hypercholesterolaemia are often found in idiopathic nephrotic syndrome (primary). Hyperuricaemia is not always associated with uric acid nephropathy due to chronic hyperuricaemia in parallel with a reduction in renal physiology. If found gaps serum urea and creatinine (without hiperkatabolisme factor), have suspected the possibility of obstructive nephropathy (lithiasis).
5)      Electrolytes
Examination of electrolytes (serum and urine) are essential for the diagnosis of CKD is associated with nephropathy (hypocalcaemia & hypokalemia) and nephrocalcinosis. examined serum  Na+, K+, HCO32- , Ca2+ , PO42-, Mg2+.
6)      Imunodiagnosis
Several checks imunodiagnosis to glomerulonephropathy include: ACB, ANA, HBsAg, Krioglobulin, CICx, examination of serum complement, imunofluoresen network
           7)  Additional ecamination
a) Plain abdominal: for identification of anatomical changes in renal
b) Ultrasonography (USG): accuracy higher than a plain photo abdomen. Useful to assess renal anatomy or identification.
c) Nephrotomogram: important for evaluation of obstructive nephropathy due mainly radiolucent stones or other causes.
d) Pielography retrograde: it is important for evaluation of obstructive nephropathy is difficult to determine why.
e) Pielography antegrade: for therapeutic and diagnosis of urinary tract obstruction.
f) Micturating cysto urography (MCU): indication of when the suspected possibility of vesicoureteric reflux.

Pathophysiology of CHRONIC KIDNEY DISEASE

PATHOPHYSIOLOGY
Pathophysiology of CKD at first depending on the underlying disease, but in the later development process that occurs more or less the same, a chronic progressive in the long run will cause a decrease in renal mass. In line with the decrease of renal mass, as a compensation mechanism that is still better then the nephron hyperfiltration therefore will experience an increase in glomerular capillary pressure and flow, and subsequent hypertrophy. Structural and functional hypertrophy of residual nephrons is still good is happening due to the influence of vasoactive molecules, cytokines and growth factor, and eventually will happen sclerosis process. Renin-action activities intravenous Angiostensin also played a role in the occurrence of hiperfilltrasi-hypertrophy and sclerosis.

 Pathophysiology that occur include:
a. Azotemia toxic (toxic metabolites)
          If there is a decrease in glomerular filtrate rate just happened retention of some toxin azotemia (U, metilguanidin, GSA). For example, GSA (guanidinosuccinic acid), these substances inhibit ADP (adenosine diphosphate) used to release platelet factor 3, so it will cause coagulation disorders.
           Although urea and serum creatinine concentration is used to measure the renal excretory capacity, the accumulation of both the molecule itself does not explain many of the symptoms and signs that characterize uremic syndrome in advanced renal failure. Hundreds of toxins that accumulate in renal failure has been involved in the uremic syndrome. These include water-soluble, hydrophobic, protein bound, charged, and uncharged compounds. Additional categories include nitrogen excretory products guanido compounds, veining and hippurates, products of the metabolism of nucleic acids, polyamines, myoinositol, phenol, benzoate, and indoles. Compounds with molecular mass between 500 and 1500 Da, which is called middle molecules, was also detained and contribute to morbidity and mortality.
           Uremic syndrome and disease state associated with renal impairment, automatically involves more than excretory renal failure. A number of metabolic and endocrine functions normally performed by the kidneys are also affected, and this results in anemia, malnutrition, and abnormal metabolism of carbohydrates, fats, and proteins. In addition, plasma levels of hormones, including PTH, insulin, glucagon, sex hormone, and prolactin, changes in renal failure as a result of urinary retention, decreased degradation, or abnormal regulation. Finally, progressive renal impairment was associated with worsening of systemic inflammation. Elevated levels of C-reactive protein was detected along with acute phase reactants, while the level of so-called negative acute phase reactants, such as albumin and fetuin, decreased with progressive renal damage. Thus, renal impairment is important in malnutrition-inflammation-atherosclerosis/calcification syndrome, which in turn contributes to the acceleration of vascular disease and comorbidities associated with advanced kidney disease.
         In summary, the pathophysiology of uremic syndrome can be divided into manifestation in the three areas of dysfunction: (1) consequent to the accumulation of toxins normally experienced renal excretion, including their protein products of metabolism, (2) consequent to the loss of others renal function, such as fluid homeostasis and electrolyte and hormonal regulation, and (3) progressive systemic inflammation and vascular and nutritional consequences

b. Trade-off hypothesis (intact nephron hyphothesis)
         According to this concept, the whole kidney physiology will be taken by the nephrons are still intact. In these nephrons have increased the concentration of solutes such as urea, resulting in osmotic diuresis to remove urea per minute which resulted in increased urine volume. This compensatory mechanism aimed at maintaining body fluid balance (homeostasis).
c. Metabolic disorders
1) Metabolism of carbohydrate
Mechanism of glucose intolerance is not known, suspected of having ties with the toxin azotemia. This hypothesis is based on the fact that glucose intolerance clinic can be corrected with intermittent hemodialysis.
2) Metabolism of fat
Hypertriglyceridemia occurs in patients with chronic renal failure undergoing intermittent hemodialysis. The mechanism is unknown, allegedly due to increased synthesis of triglyceride-rich lipoproteins in the liver.
3) Metabolism of proteins
In the normal restrictions on the amount of protein in a long time can cause a negative balance of nitrogen. In contrast to patients with CKD restrictions on the amount of protein in the menu will not cause a negative balance of nitrogen.
4) Metabolism of uric acid
Hyperuricaemia is common in CKD, although the increase in serum uric acid has no relation with the degree of decline in renal physiology. For the process is still not clear.
5) Electrolyte Metabolism
a)      Metabolism of Na
Natriuretic hormone or suspected presence of factors that inhibit reabsorption of sodium ions in the renal tubules causing increased excretion of sodium. When the renal physiology continued to deteriorate with decrease in nephron-nephron number that is still intact, increased natriuresis.
b)      Water Metabolism
In some patients with CKD by increasing the number of nephrons is reduced, flexibility for the excretion of water will also be reduced so easily happen poisoning of water (water overload) both renal and extra renal causes hyponatremia.
c)      Metabolism of potassium
Hypokalemia can be found in patients with CKD caused by poor dietary potassium, a powerful diuretic that is not controlled, secondary hyperaldosteronism from volume depletion and tubular diseases such as Fanconi syndrome, and because of interstitial nephritis.
d)     acid-base balance
Pathogenesis of metabolic acidosis in CKD are:
(1) decrease the excretion of ammonia due to loss of nephron number.
(2) decrease the excretion of titrable acid, especially phosphate, because the intake and absorption through the intestines is reduced.
(3) Loss of a number of bicarbonate through the urine (bicarbonate wasting).
e) Calcium Metabolism
In patients with CKD often found hypocalcemia, due to decreased Ca absorption through the gut and impaired mobilization of Ca and hyperphosphatemia.
e)      Phosphorus
f)   Hyperphosphatemia that occurs in CKD plays an important role to arise hypocalcemia and hyperparathyroidism, and ultimately can cause the spread of calcification in other organs (metastatic calcification).
g)       Magnesium
The increase in serum magnesium very rarely cause complaints or symptoms, except for magnesium-containing antacids laxative and will suppress the Central Nervous System.


for Indonesian Language click here

related articles
1. Pathophysiology of Chronic Kidney Disease
2. Chronic Kidney Disease
3. How to Diagnose Chronic Kidney Disease
4. How to Treat and therapy of Chronic Kidney Disease



 

Medical and Health Information Copyright © 2012 Fast Loading -- Powered by Blogger